139 related articles for article (PubMed ID: 33218825)
1. Re: Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer.
da Silva FC; Algaba F
Eur Urol; 2021 Feb; 79(2):318-319. PubMed ID: 33218825
[No Abstract] [Full Text] [Related]
2. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer.
Lotan TL; Tomlins SA; Bismar TA; Van der Kwast TH; Grignon D; Egevad L; Kristiansen G; Pritchard CC; Rubin MA; Bubendorf L
Am J Surg Pathol; 2020 Jul; 44(7):e15-e29. PubMed ID: 32044806
[TBL] [Abstract][Full Text] [Related]
3. The International Society of Urological Pathology Consultation on Molecular Pathology of Urogenital Cancer.
van der Kwast TH; Egevad L; Kristiansen G; Grignon DJ
Am J Surg Pathol; 2020 Jul; 44(7):859-861. PubMed ID: 32341239
[TBL] [Abstract][Full Text] [Related]
4. [Interpretation and research advances on molecular biomarkers in prostate cancer from 2020 International Society of Urological Pathology consultation conference report].
Hu J; Han B
Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):172-176. PubMed ID: 33535320
[TBL] [Abstract][Full Text] [Related]
5. [Molecular pathology of urogenital tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference].
Hommerding O; Allory Y; Argani P; Bismar TA; Bubendorf L; Canete-Portillo S; Chaux A; Chen YB; Cheng L; Cubilla AL; Egevad L; Gill AJ; Grignon DJ; Hartmann A; Hes O; Idrees MT; Kao CS; Knowles MA; Looijenga LHJ; Lotan TL; Pritchard CC; Rubin MA; Tomlins SA; Van der Kwast TH; Velazquez EF; Warrick JI; Williamson SR; Kristiansen G
Pathologe; 2021 May; 42(3):310-318. PubMed ID: 33398501
[TBL] [Abstract][Full Text] [Related]
6. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
7. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers V: Recommendations on the Use of Immunohistochemical and Molecular Biomarkers in Penile Cancer.
Canete-Portillo S; Velazquez EF; Kristiansen G; Egevad L; Grignon D; Chaux A; Cubilla AL
Am J Surg Pathol; 2020 Jul; 44(7):e80-e86. PubMed ID: 32235153
[TBL] [Abstract][Full Text] [Related]
8. Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges.
Warrick JI; Knowles MA; Yves A; van der Kwast T; Grignon DJ; Kristiansen G; Egevad L; Hartmann A; Cheng L
Am J Surg Pathol; 2020 Jul; 44(7):e30-e46. PubMed ID: 32091435
[TBL] [Abstract][Full Text] [Related]
9. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.
Iczkowski KA; van Leenders GJLH; van der Kwast TH
Am J Surg Pathol; 2021 Jul; 45(7):1007. PubMed ID: 33481387
[No Abstract] [Full Text] [Related]
10. Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conference.
Amin MB; Epstein JI; Ulbright TM; Humphrey PA; Egevad L; Montironi R; Grignon D; Trpkov K; Lopez-Beltran A; Zhou M; Argani P; Delahunt B; Berney DM; Srigley JR; Tickoo SK; Reuter VE;
Am J Surg Pathol; 2014 Aug; 38(8):1017-22. PubMed ID: 25025364
[TBL] [Abstract][Full Text] [Related]
11. Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations.
Egevad L; Delahunt B; Kristiansen G; Samaratunga H; Varma M
Pathology; 2018 Jan; 50(1):60-73. PubMed ID: 29199015
[TBL] [Abstract][Full Text] [Related]
12. International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.
Egevad L; Delahunt B; Srigley JR; Samaratunga H
APMIS; 2016 Jun; 124(6):433-5. PubMed ID: 27150257
[TBL] [Abstract][Full Text] [Related]
13. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
[TBL] [Abstract][Full Text] [Related]
14. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
[TBL] [Abstract][Full Text] [Related]
15. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
Epstein JI; Egevad L; Humphrey PA; Montironi R;
Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
[TBL] [Abstract][Full Text] [Related]
16. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
[TBL] [Abstract][Full Text] [Related]
17. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
[TBL] [Abstract][Full Text] [Related]
18. Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups.
Bakir B; Onay A; Vural M; Armutlu A; Yıldız SÖ; Esen T
AJR Am J Roentgenol; 2020 Mar; 214(3):588-596. PubMed ID: 31670596
[No Abstract] [Full Text] [Related]
19. [Grading of prostate cancer].
Kristiansen G; Roth W; Helpap B
Pathologe; 2016 Jul; 37(4):352-4. PubMed ID: 27393141
[TBL] [Abstract][Full Text] [Related]
20. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis.
Berg KD; Thomsen FB; Nerstrøm C; Røder MA; Iversen P; Toft BG; Vainer B; Brasso K
BJU Int; 2016 Jun; 117(6):883-9. PubMed ID: 26823232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
